Rohan Gajjar

ORCID: 0000-0002-2860-2594
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • COVID-19 Clinical Research Studies
  • Heart Failure Treatment and Management
  • Cardiovascular Health and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Mechanical Circulatory Support Devices
  • Infective Endocarditis Diagnosis and Management
  • Long-Term Effects of COVID-19
  • Peripheral Artery Disease Management
  • Cardiac Structural Anomalies and Repair
  • Acute Myocardial Infarction Research
  • Liver Disease Diagnosis and Treatment
  • Healthcare Systems and Public Health
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Liver Disease and Transplantation
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 and healthcare impacts
  • Cardiovascular Function and Risk Factors
  • Viral Infections and Immunology Research
  • Congenital Heart Disease Studies
  • Blood Pressure and Hypertension Studies
  • Intensive Care Unit Cognitive Disorders

John H. Stroger, Jr. Hospital of Cook County
2023-2025

Northeast Georgia Medical Center
2024

Cook County Health and Hospitals System
2023-2024

Mayo Clinic
2024

Medical College of Wisconsin
2024

Korle Bu Teaching Hospital
2024

Maimonides Medical Center
2024

Prisma Health
2024

Institute of Medical Sciences
2024

Mayo Clinic in Arizona
2023

Hospital readmissions serve as a significant negative prognostic indicator and have considerable impact on healthcare utilization among individuals diagnosed with heart failure preserved ejection fraction (HFpEF). For our study, we aimed to elucidate predictors trends of HFpEF within 30-day period. The Healthcare Cost Utilization Project National Readmission Database (NRD) was queried between 2016-2020 study the all-cause hospital readmission rate, predictors, duration stay, overall cost...

10.36628/ijhf.2024.0041 article EN cc-by-nc International Journal of Heart Failure 2025-01-01

Background Despite extensive research on COVID-19 and its association with myocarditis, limited data are available readmission rates for this subset of patients. Thirty-day hospital rate is an established quality metric that associated increased mortality cost.

10.1080/08998280.2024.2325280 article EN Baylor University Medical Center Proceedings 2024-03-19

Abstract Aims Aortic valve calcification (AVC) is prognostic in patients with aortic stenosis (AS). We assessed the AVC value non-severe AS patients. Methods and results conducted a retrospective study of 395 AS, LVEF ≥ 50%. The Agatston method was used for CT assessment. log-rank test determined best cut-offs survival under medical surveillance: 1185 arbitrary unit (AU) men 850 AU women, lower than established severe (2064 1274 women). Patients were divided into 3 groups based on these...

10.1093/ehjci/jeae145 article EN European Heart Journal - Cardiovascular Imaging 2024-06-03

Background The impact of long-term systemic steroid use on electrical and mechanical complications following ST-segment elevation myocardial infarction (STEMI) has not been extensively studied. Methods In a retrospective cohort study the National Inpatient Sample (NIS) from 2018 to 2020, adults admitted with STEMI were dichotomized based presence (current) (LTCSS) use. primary outcome was all-cause mortality. Secondary outcomes included composite complications, electrical, hemodynamic,...

10.7759/cureus.55154 article EN Cureus 2024-02-28

Catheter Directed Interventions (CDIs) for Pulmonary Embolism have been present years but their use has limited due to paucity of data. We aim compare these interventions in patients with and without liver cirrhosis. The National Readmission Database (2016-2020) was utilized identify CDIs (thrombectomy & thrombolysis) acute pulmonary embolism (PE) cor pulmonale. Cohorts were stratified based on Liver Cirrhosis. A Propensity Score Matching (PSM) model, matched cirrhotics non-cirrhotics....

10.1016/j.jscai.2024.101841 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Hepatitis C (HCV) is a viral infection responsible for chronic inflammation resulting in fibrosis, cirrhosis, and liver cancer. Several studies describe an association between HCV cardiovascular (CV) disease/risk factors including increased risk of diabetes mellitus, accelerated atherosclerosis, coronary/carotid artery disease. Nevertheless, data limited, so our aim to further study this association. Utilizing the Nationwide Inpatient Sample Database from 2016-2019, we studied patients with...

10.1016/j.jscai.2024.101669 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Right ventricular dysfunction (RVD) continues to be a significant contributor both mortality and morbidity, posing persistent challenge in the hemodynamics of patients undergoing evaluation for mechanical circulatory support (MCS) devices as Intra-aortic balloon pump (IABP). We sought analyze characteristics outcomes IABP with RVD versus those without RVD. The 2016-2020 National Inpatient Sample database (NIS) was analyzed identify adult hospitalizations who underwent placement or...

10.1016/j.jscai.2024.101722 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Anemia is known to be associated with adverse outcomes in several cardiac procedures. Recent data suggest poorer patient baseline anemia undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI). To date, has not been included risk score predictors for CTO PCI. We conduct a meta-analysis explore the association between and conducted literature search from inception through January 2024 EMBASE MEDLINE databases. studies that report PCI patients without anemia. Baseline...

10.1016/j.jscai.2024.101742 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

The association between liver cirrhosis & cardiovascular diseases is still a matter of debate. We aim to compare ST elevation MI (STEMI) outcomes in patients with without cirrhosis. national readmission database (2016-2020) was utilized identify hospitalizations for STEMI. Cohorts were stratified by A propensity score matching (PSM) model implemented Pearson's x2 test on matched cohorts outcomes. Among 1 million STEMI; 45,478 (4.4%) had history After (N=24,067), cirrhotic higher in-hospital...

10.1016/j.jscai.2024.101502 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Anemia is known to be associated with adverse outcomes in several cardiac procedures. Recent data suggest patients baseline anemia undergoing mitral transcutaneous edge-to-edge valve repair (TEER) MitraClip. However, was not conclusive. We conduct a meta-analysis explore the association between and TEER. conducted literature search from inception through January 2024 EMBASE MEDLINE databases. included studies that report TEER without anemia. Baseline defined by hemoglobin level of < 13 g/dL...

10.1016/j.jscai.2024.101626 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Cardiovascular Disease is the leading cause of death among women; however acute coronary events tend to be under-managed in females due atypical presentation & delay diagnosis. We aim investigate gender disparities ST-elevation myocardial infarction (STEMI) outcomes. The national readmission database (2016-2020) was queried identify hospitalizations for STEMI. Cohorts were stratified based by gender. A propensity score matching (PSM) model matched males and with Pearson's x 2 test applied...

10.1016/j.jscai.2024.101523 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Coronary artery disease (CAD) is a leading cause of morbidity and mortality in patients with advanced chronic kidney (CKD) End Stage Renal Disease (ESRD). While revascularization remains pivotal therapy for CAD, current literature describing treatment outcomes comorbid CKD ESRD limited. We sought to explore in-hospital predictors adverse among this population. A retrospective cohort study was conducted data from the 2016 2020 combined National Inpatient Sample database. The individuals (CKD5...

10.1016/j.jscai.2024.101670 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Chronic Total Occlusion Percutaneous Coronary Intervention (CTO-PCI) poses a distinct technical challenge with increased risk of periprocedural complications unclear benefits. We sought to explore its effect in patients history Ventricular Tachycardia (VT). National Inpatient Sample (2016-2020) was queried identify adults CTO and VT, which were stratified based on PCI using ICD-10-CM PCS codes. All acute myocardial infarction excluded. Controls derived propensity score matching for...

10.1016/j.jscai.2024.101671 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Chronic Total Occlusion (CTO) revascularization poses a distinct technical challenge with increased risk of periprocedural complications without certain benefits. Literature looking into Long term effects in patients Ventricular Tachycardia (VT) is limited. We looked at readmissions as marker for long effect. Nationwide Readmissions Database 2020 was queried to identify adults CTO-VT and (PCI or Coronary Artery Bypass Grafting) using ICD-10 CM PCS codes. All acute myocardial infarction were...

10.1016/j.jscai.2024.101672 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01
Coming Soon ...